Key history elements (most yield, fewest assumptions): Temporal relationship : symptom onset vs semaglutide initiation, dose escalation, peak GI symptoms (which cluster early in treatment), and weight change trajectory
This highlights the need for ongoing research to clarify the potential risks associated with GLP-1 agonists and thyroid health
Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A
Flexible Spending Accounts (FSA) or Health Savings Accounts (HSA) Many patients use FSA or HSA funds to pay for semaglutide prescriptions, consultations, and related medical supplies
Large clinical trials show that semaglutide can significantly reduce the risk of heart attack, stroke, and cardiovascular death in certain populations
While both fall under the umbrella of "incretin mimetics," their unique biological actions can produce very different outcomes